The 2026 Multi-Society Dyslipidemia Guideline represents one of the most significant paradigm shifts in cardiovascular risk management in over a decade, yet substantial practice gaps persist. Clinicians across primary care, cardiology, endocrinology, and internal medicine continue to underutilize non-statin therapies, struggle with risk stratification, and face barriers to treatment goal attainment, leaving patients at preventable risk for ASCVD events. Month 2: Risk Assessment Reimagined 1. Review the new PREVENT risk model. 2. Identify when to measure ApoB and Lp(a). 3. Apply coronary artery calcium (CAC) scoring appropriately. 4. Use risk enhancers to guide therapy decisions.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Address:
- 6816 Southpoint Parkway
Pricing
CME included with membership · $195/yr
| Regular Membership (1 year) | $195/yr |
| Regular Membership (3 years) | $510 |
| International Membership (1 year) | $195/yr |
| International Membership (3 years) | $510 |
| Industry Membership (1 year) | $195/yr |
| Industry Membership (3 years) | $510 |
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Podcast / audio
- Credit · Up to 0.5 credits
- Commercial Support
-
ReleasedSep 30, 2026
-
Last day to claim creditMar 31, 2027 6 months left
-
National Lipid Association From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice – Understanding the New Dyslipidemia Paradigm: Podcast
-
National Lipid Association From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice – Treatment Strategies and Targets: Podcast
-
National Lipid Association From Cholesterol to Dyslipidemia: Translating the 2026 Multi-Society Guideline into Clinical Practice – Non-Statin Therapies and Emerging Treatments: Podcast
